While CSF3R mutations are most commonly found in severe congenital neutropenia (SCN), the rates of CSF3R mutations rises sharply upon progression to secondary acute myeloid leukemia (sAML) [4–6]. The gene discussed is CSF3R; the disease is acute myeloid leukemia.